Bodhi Tree Biotechnology Inc. (BDTB)

Bodhi Tree Biotechnology Cash Flow Statement

Financials in millions USD. Fiscal year is October - September.

Operating Activities

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Mar 31, 2026	Sep 30, 2025	Sep 30, 2024
Net Income	-0.11	-0.15	-0.07
Change in Other Net Operating Assets	-0.01	-0	-0.01
Operating Cash Flow	-0.12	-0.15	-0.09
Operating Cash Flow Growth	-	-	-

Financing Activities

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Mar 31, 2026	Sep 30, 2025	Sep 30, 2024
Issuance of Common Stock	-	-	0.4
Financing Cash Flow	-	-	0.4

Net Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Mar 31, 2026	Sep 30, 2025	Sep 30, 2024
Net Cash Flow	-0.12	-0.15	0.31

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Mar 31, 2026	Sep 30, 2025	Sep 30, 2024
Cash Income Tax Paid	0	0	-
Change in Working Capital	-0.01	-0	-0.01

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 9, 2026

Data Sources Report a data error